Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (601-610 of 645) with videos related to

Pageof 65
Sort By:
European Journal of Heart Failure|May 16, 2023
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trialKamilė Čerlinskaitė-Bajorė, Carolyn S P Lam, Karen Sliwa, et al.
Circulation. Heart Failure|March 6, 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF TrialJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
European Journal of Heart Failure|September 9, 2015
Signature of circulating microRNAs in patients with acute heart failureEkaterina S Ovchinnikova, Daniela Schmitter, Eline L Vegter, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
European Journal of Heart Failure|November 22, 2023
Rationale and design of the ESC Heart Failure III Registry - Implementation and discoveryLars H Lund, Maria Generosa Crespo-Leiro, Cecile Laroche, et al.
Cardiac Failure Review|June 24, 2026
A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert GroupOvidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al.
International Journal of Cardiology|May 28, 2016
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinionMarkku S Nieminen, Michael Buerke, Alain Cohen-Solál, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
European Journal of Heart Failure|September 11, 2024
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III RegistryLars H Lund, Maria Generosa Crespo-Leiro, Cécile Laroche, et al.
Pageof 65

Showing results (601-610 of 645) with videos related to

Sort By:
Pageof 65
European Journal of Heart Failure|May 16, 2023
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trialKamilė Čerlinskaitė-Bajorė, Carolyn S P Lam, Karen Sliwa, et al.
Circulation. Heart Failure|March 6, 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF TrialJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
European Journal of Heart Failure|September 9, 2015
Signature of circulating microRNAs in patients with acute heart failureEkaterina S Ovchinnikova, Daniela Schmitter, Eline L Vegter, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
European Journal of Heart Failure|November 22, 2023
Rationale and design of the ESC Heart Failure III Registry - Implementation and discoveryLars H Lund, Maria Generosa Crespo-Leiro, Cecile Laroche, et al.
Cardiac Failure Review|June 24, 2026
A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert GroupOvidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al.
International Journal of Cardiology|May 28, 2016
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinionMarkku S Nieminen, Michael Buerke, Alain Cohen-Solál, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
European Journal of Heart Failure|September 11, 2024
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III RegistryLars H Lund, Maria Generosa Crespo-Leiro, Cécile Laroche, et al.
Pageof 65